Myopia Progression After Ceasing Myopia Control Contact Lens Wear

Inclusion criteria

• The subject must be enrolled in the parent protocol for at least one year.
• The subject's parent or legal guardian must read and sign the STATEMENT OF INFORMED CONSENT and the subject must read and sign the Child's Assent Form and be provided a copy of each form.
• The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

Exclusion criteria

• Ocular or systemic allergies that may interfere with contact lens wear.
• Systemic disease or autoimmune disease or use of medication (e.g. antihistamine), which may interfere with contact lens wear.
• Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear.
• Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that might interfere with contact lens wear.
• Any ocular infection.
• Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• Any infectious disease (e.g. hepatitis, tuberculosis) or an immunosuppressive disease (e.g. HIV)
• Diabetes
• Previous refractive surgery, orthokeratology, keratoconus, or other corneal irregularity in either eye. Rigid contact lens wearers cannot be enrolled in the study.
• Strabismus.
• Pupil or lid abnormality or infection in either eye
• Central corneal scar in either eye
• Aphakia in either eye
• Contraindications to contact lens wear such as dry eye or history of prior unsuccessful contact lens wear.
• History of participation in prior clinical trials aimed to control myopia progression, except for the parent trial
• Surgically altered eyes, ocular infection of any type, ocular inflammation.
• Anterior chamber angle grade 2 or narrower by Van Herrick method.